Burgeon Healthcares
BRUCOX-P is an advanced analgesic formulation designed to deliver targeted pain control with clinical precision.
Combining Etoricoxib 60 mg, a selective COX-2 inhibitor, with Paracetamol 325 mg, a trusted antipyretic and analgesic, BRUCOX-P offers a synergistic approach to managing pain and inflammation.
Engineered to meet modern therapeutic standards, BRUCOX-P is an ideal choice for musculoskeletal pain, post-operative discomfort, arthritis management, and inflammatory conditions requiring dependable relief.
Crafted with pharmaceutical excellence and clinical confidence, BRUCOX-P represents strength, precision, and performance in pain management.